Micro-Macinazione USA, bioRASI, Lowe Enterprises, O’Connor Capital Partners, Gutierrez Co. | GenomeWeb
Swiss Clinical Manufacturer Expanding Into US With New Tarrytown, NY, Facility
 
The US subsidiary of a Swiss clinical manufacturer serving the biopharma industry has chosen New York over New Jersey for the site of a new micronization facility it plans to open in the US.
 
Micro-Macinazione USA plans to lease 10,000 square feet within The Landmark at Eastview, a 750,000-square-foot Tarrytown, NY, office-lab campus operated by BioMed Realty Trust.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.